Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study (vol 4, pg 211, 2016)

被引：1
作者：
Weber, M. A.
Mansfield, T. A.
Cain, V. A.
Iqbal, N.
Parikh, S.
Ptaszynska, A.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2016年 / 4卷 / 03期
关键词：
D O I：
10.1016/S2213-8587(15)00467-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E3 / E3
页数：1
相关论文
共 50 条
  • [21] Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study (vol 6, pg 627, 2018)
    Zhu, D.
    Gan, S.
    Liu, Y.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (08) : E16 - E16
  • [22] Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: a randomised, double-blind, placebo-controlled crossover trial
    Laursen, J. C.
    Heinrich, N. Sondergaard
    de Melo, J. M. L.
    Haddock, B.
    Rasmussen, I. K. B.
    Safavimanesh, F.
    Hansen, C. Stevns
    Storling, J.
    Larsson, H. B. Wiberg
    Groop, P. -H.
    Frimodt-Moller, M.
    Andersen, U. B.
    Rossing, P.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 121 - 121
  • [23] Combination Treatment With Ipragliflozin and Metformin: A Randomized, Double-Blind, Placebo-Controlled Study in Patients With Type 2 Diabetes Mellitus
    Veltkamp, Stephan A.
    van Dijk, Jan
    Collins, Christiane
    van Bruijnsvoort, Michel
    Kadokura, Takeshi
    Smulders, Ronald A.
    CLINICAL THERAPEUTICS, 2012, 34 (08) : 1761 - 1771
  • [24] Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
    Tsimikas, Sotirios
    Viney, Nicholas J.
    Hughes, Steven G.
    Singleton, Walter
    Graham, Mark J.
    Baker, Brenda F.
    Burkey, Jennifer L.
    Yang, Qingqing
    Marcovina, Santica M.
    Geary, Richard S.
    Crooke, Rosanne M.
    Witztum, Joseph L.
    LANCET, 2015, 386 (10002) : 1472 - 1483
  • [25] Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study
    Naehrlich, Lutz
    Mainz, Jochen G.
    Adams, Constantin
    Engel, Corinna
    Herrmann, Gloria
    Icheva, Vanya
    Lauer, Josefine
    Deppisch, Caroline
    Wirth, Andreas
    Unger, Katy
    Graepler-Mainka, Ute
    Hector, Andreas
    Heyder, Susanne
    Stern, Martin
    Doering, Gerd
    Gulbins, Erich
    Riethmueller, Joachim
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 31 (4-5) : 505 - 512
  • [26] Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial
    Laursen, Jens Christian
    Sondergaard-Heinrich, Niels
    de Melo, Joana Mendes Lopes
    Haddock, Bryan
    Rasmussen, Ida Kirstine Bull
    Safavimanesh, Farzaneh
    Hansen, Christian Stevns
    Storling, Joachim
    Larsson, Henrik Bo Wiberg
    Groop, Per-Henrik
    Frimodt-Moller, Marie
    Andersen, Ulrik Bjorn
    Rossing, Peter
    ECLINICALMEDICINE, 2021, 37
  • [27] Antihypertensive Effects of Lactotripeptides on Unattended Office and Abulatory Blood Pressure. A Randomized, Double-blind, Placebo-controlled Study
    Crippa, Giuseppe
    Rossi, Filippo
    Bravi, Elena
    Fontana, Manuela
    Zabzuni, Dorjan
    HYPERTENSION, 2017, 70
  • [28] Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)
    Lee, Byung Wan
    Min, KyungWan
    Hong, Eun-Gyoung
    Ku, Bon Jeong
    Kang, Jun Goo
    Chon, Suk
    Lee, Won-Young
    Park, Mi Kyoung
    Kim, Jae Hyeon
    Kim, Sang Yong
    Song, Keeho
    Yoo, Soon Jib
    ENDOCRINOLOGY AND METABOLISM, 2023, 38 (03) : 328 - 337
  • [29] Empagliflozin reduces blood pressure in patients with Type 2 diabetes and hypertension: a phase III, randomised, double-blind, placebo-controlled trial (EMPA-REG BP™)
    Tikkanen, I.
    Narko, K.
    Zeller, C.
    Green, A.
    Salsali, A.
    Broedl, U. C.
    Woerle, H. J.
    DIABETIC MEDICINE, 2014, 31 : 64 - 64
  • [30] Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study
    Jeong, In-Kyung
    Choi, Kyung Mook
    Han, Kyung Ah
    Kim, Kyoung-Ah
    Kim, In Joo
    Han, Seung Jin
    Lee, Won Young
    Yoo, Soon Jib
    DIABETES OBESITY & METABOLISM, 2024, 26 (11) : 5065 - 5077
12345